2016
DOI: 10.2105/ajph.2016.303437
|View full text |Cite
|
Sign up to set email alerts
|

Leading-Brand Advertisement of Quitting Smoking Benefits for E-Cigarettes

Abstract: These results can help the Food and Drug Administration clarify whether tobacco products should be regulated as drugs with therapeutic purpose or as recreational products.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
34
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 42 publications
(34 citation statements)
references
References 14 publications
0
34
0
Order By: Relevance
“…E-cigarette companies are known to use a variety of euphemistic phrases to suggest that their products can be used for cessation. 50 Despite not making overt cessation claims, these messages may serve as cessation claims.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…E-cigarette companies are known to use a variety of euphemistic phrases to suggest that their products can be used for cessation. 50 Despite not making overt cessation claims, these messages may serve as cessation claims.…”
Section: Discussionmentioning
confidence: 99%
“…55 No currently marketed e-cigarettes have received FDA authorization to make harm reduction or cessation claims. 55 By stating that e-cigarettes are less harmful than cigarettes and implicitly suggesting e-cigarettes could be used for cessation, 50 harm reduction messages, like the one tested in this study, may not be allowed by FDA or other regulatory agencies.…”
Section: Implications For Tobacco Regulationmentioning
confidence: 99%
“…10 Cessation and health-related claims are also prevalent in e-cigarette marketing. [11][12][13] While e-cigarettes have been found to contain lower amounts of many toxicants than conventional cigarettes, 14,15 the long-term health effects of e-cigarettes are unknown. Furthermore, concerns remain about the potential toxicity of some components of e-cigarettes, such as flavorings.…”
Section: Introductionmentioning
confidence: 99%
“…can ENDS aid smoking cessation; do young ENDS users become smokers; what are the health effects among Box 1 Evidence on electronic nicotine delivery systems (ENDS) deemed to be substantial or conclusive [1] • ENDS use among young people increases the risk of future combustible tobacco use • Although rare, ENDS devices can explode, causing harm to users • Direct e-liquid contact (e.g. Further, as ENDS are marketed as 'switching', rather than quitting, devices, they also elude the restriction on cessation claims [7], despite ENDS now being the leading product used by US adult smokers attempting to reduce or quit combustibles [8]. formaldehyde, acrolein); can induce oxidative stress, although generally at levels lower than combustible cigarettes; and can induce acute endothelial cell dysfunction • ENDS emissions increase nicotine and particulate matter in indoor environments • ENDS, when completely substituted for combustible cigarettes, can reduce toxicant exposures dual users?).…”
mentioning
confidence: 99%
“…As a result, there is no incentive for ENDS manufacturers to invest in the regulatory process for FDA approval of therapeutic claims. Further, as ENDS are marketed as 'switching', rather than quitting, devices, they also elude the restriction on cessation claims [7], despite ENDS now being the leading product used by US adult smokers attempting to reduce or quit combustibles [8]. Meanwhile, US researchers remain unable to empirically evaluate ENDS as a treatment for quitting smoking.…”
mentioning
confidence: 99%